Vor Biopharma Balance Sheet
NASDAQ: VORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vor Biopharma financial position
At the end of fiscal 2025, Vor Biopharma reported total assets of $464.1 million, up 224.8% from a year earlier against total liabilities of $628.4 million. Shareholders' equity was negative at -$164.3 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $396.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 18.20, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Vor Biopharma balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 396.49M | 81.95M | 31.36M | 57.71M | 119.80M | 48.54M |
| Short-Term Investments | 58.72M | 9.98M | 105.81M | 172.54M | 87.67M | 0 |
| Total Current Assets | 458.11M | 96.51M | 140.80M | 236.95M | 214.40M | 49.11M |
| Property, Plant & Equipment | 533.00K | 6.58M | 10.05M | 12.63M | 6.85M | 4.73M |
| Total Assets | 464.13M | 142.89M | 198.13M | 299.37M | 242.59M | 75.91M |
| Accounts Payable | 5.13M | 1.50M | 815.00K | 1.77M | 1.54M | 2.36M |
| Total Current Liabilities | 25.17M | 18.61M | 15.57M | 13.12M | 10.15M | 10.21M |
| Total Liabilities | 628.44M | 46.23M | 47.40M | 48.76M | 26.33M | 27.64M |
| Shareholders' Equity | -164.31M | 96.66M | 150.72M | 250.61M | 216.26M | -59.06M |
| Retained Earnings | -1.15B | -456.99M | -340.08M | -222.22M | -130.12M | -61.22M |
| Net Cash (Debt) | 455.21M | 91.93M | 137.18M | 230.25M | 207.47M | 48.54M |
| Shares Outstanding | 38.72M | 6.24M | 67.89M | 66.00M | 37.17M | 505.07K |
This table shows 6 annual periods of Vor Biopharma's balance sheet, from FY 2025 back to FY 2020, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow VOR's reporting calendar. What is a balance sheet?